Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults
- PMID: 29698488
- PMCID: PMC5940242
- DOI: 10.1371/journal.pntd.0006377
Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults
Abstract
Hepatitis delta virus (HDV) increases morbidity in Hepatitis B virus (HBV)-infected patients. In the mid-eighties, an outbreak of HDV fulminant hepatitis (FH) in the Central African Republic (CAR) killed 88% of patients hospitalized in Bangui. We evaluated infections with HBV and HDV among students and pregnant women, 25 years after the fulminant hepatitis (FH) outbreak to determine (i) the prevalence of HBV and HDV infection in this population, (ii) the clinical risk factors for HBV and/or HDV infections, and (iii) to characterize and compare the strains from the FH outbreak in the 1980s to the 2010 HBV-HDV strains. We performed a cross sectional study with historical comparison on FH-stored samples (n = 179) from 159 patients and dried blood-spots from volunteer students and pregnant women groups (n = 2172). We analyzed risk factors potentially associated with HBV and HDV. Previous HBV infection (presence of anti-HBc) occurred in 345/1290 students (26.7%) and 186/870 pregnant women (21.4%)(p = 0.005), including 110 students (8.8%) and 71 pregnant women (8.2%), who were also HBsAg-positive (p = 0.824). HDV infection occurred more frequently in pregnant women (n = 13; 18.8%) than students (n = 6; 5.4%) (p = 0.010). Infection in childhood was probably the main HBV risk factor. The risk factors for HDV infection were age (p = 0.040), transfusion (p = 0.039), and a tendency for tattooing (p = 0.055) and absence of condom use (p = 0.049). HBV-E and HDV-1 were highly prevalent during both the FH outbreak and the 2010 screening project. For historical samples, due to storage conditions and despite several attempts, we could only obtain partial HDV amplification representing 25% of the full-length genome. The HDV-1 mid-eighties FH-strains did not form a specific clade and were affiliated to two different HDV-1 African subgenotypes, one of which also includes the 2010 HDV-1 strains. In the Central African Republic, these findings indicate a high prevalence of previous and current HBV-E and HDV-1 infections both in the mid-eighties fulminant hepatitis outbreak and among asymptomatic young adults in 2010, and reinforce the need for universal HBV vaccination and the prevention of HDV transmission among HBsAg-positive patients through blood or sexual routes.
Conflict of interest statement
PD and NPK report grants from Agence Nationale de recherche sur le Sida et les Hépatites virales (ANRS #12202) PD reports grants from Institut National de la Santé et la Recherche Médicale, non-financial support from Siemens Diagnostics, during the conduct of the study; personal fees from Gilead, outside the submitted work; In addition, PD has a patent Dény Paul, Radjef Nadjia, Huc-Anais Patricia, Molécules d’acides nucléiques d’HDV, leurs fragments et leurs applications, 01 12285 issued to Assistance Publique – Hôpitaux de Paris le 24 septembre 2001; Extension internationale PCT/FR02/03239 au nom de Assistance Publique – Hôpitaux de Paris le 23 septembre 2002, - PD and FLG have a patent Dény Paul, Gault Elyanne, Le Gal Frédéric, « Quantitative detection of HDV » issued to Assistance Publique – Hôpitaux de Paris le 6 aout 2004; Extension internationale PCT/IB2005/002628 au nom de Assistance Publique – Hôpitaux de Paris le 27 juillet 2005. All the other authors have no conflict of interest.
Figures
References
-
- WHO. Global hepatitis report, 2017 Geneva: WHO Press, World Health Organization; 2017.
-
- Alfaiate D, Dény P, Durantel D. Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options. Antiviral research. 2015;122:112–29. doi: 10.1016/j.antiviral.2015.08.009 - DOI - PubMed
-
- Rizzetto M. The adventure of delta. Liver international: official journal of the International Association for the Study of the Liver. 2016;36 Suppl 1:135–40. - PubMed
-
- Smedile A, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, et al. Influence of delta infection on severity of hepatitis B. Lancet (London, England). 1982;2(8305):945–7. - PubMed
-
- Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009;136(5):1629–38. doi: 10.1053/j.gastro.2009.01.052 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
